Characteristics of Myocardial Perfusion in Type 2 Diabetes Mellitus and Its Association with Left Ventricular Diastolic Dysfunction: A Study of Myocardial Contrast Echocardiography

References

• Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213–3223. doi:10.1161/circulationaha.106.679597
   PubMed Web of Science ®Google Scholar
• Tillquist MN, Maddox TM. Update on diabetic cardiomyopathy: inches forward, miles to go. Curr Diab Rep. 2012;12(3):305–313. doi:10.1007/s11892-012-0274-7
   PubMed Web of Science ®Google Scholar
• Huynh K, Bernardo BC, McMullen JR, Ritchie RH. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther. 2014;142(3):375–415. doi:10.1016/j.pharmthera.2014.01.003
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care. BMJ. 2016;354:i3477. doi:10.1136/bmj.i3477
   PubMed Web of Science ®Google Scholar
• Cubbon RM, Adams B, Rajwani A, et al. Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology. Diab Vasc Dis Res. 2013;10(4):330–336. doi:10.1177/1479164112471064
   PubMed Web of Science ®Google Scholar
• Paolillo S, Marsico F, Prastaro M, et al. Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications. Heart Fail Clin. 2019;15(3):341–347. doi:10.1016/j.hfc.2019.02.003
   PubMed Web of Science ®Google Scholar
• Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004;27(3):699–703. doi:10.2337/diacare.27.3.699
   PubMed Web of Science ®Google Scholar
• Grigorescu ED, Lacatusu CM, Floria M, Mihai BM, Cretu I, Sorodoc L. Left ventricular diastolic dysfunction in type 2 diabetes-progress and perspectives. Diagnostics. 2019;9(3). doi:10.3390/diagnostics9030121
   Web of Science ®Google Scholar
• Vinereanu D, Nicolaides E, Tweddel AC, et al. Subclinical left ventricular dysfunction in asymptomatic patients with Type II diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond). 2003;105(5):591–599. doi:10.1042/cs20030168
   PubMed Web of Science ®Google Scholar
• Patil MB, Burji NP. Echocardiographic evaluation of diastolic dysfunction in asymptomatic type 2 diabetes mellitus. J Assoc Physicians India. 2012;60:23–26.
   PubMedGoogle Scholar
• Ernande L, Bergerot C, Rietzschel ER, et al. Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr. 2011;24(11):1268–1275.e1261. doi:10.1016/j.echo.2011.07.017
   PubMed Web of Science ®Google Scholar
• Lorenzo-Almorós A, Tuñón J, Orejas M, Cortés M, Egido J, Lorenzo Ó. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol. 2017;16(1):28. doi:10.1186/s12933-017-0506-x
   PubMed Web of Science ®Google Scholar
• Senior R, Becher H, Monaghan M, et al. Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017. Eur Heart J Cardiovasc Imaging. 2017;18(11):1205–1205af. doi:10.1093/ehjci/jex182
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes–2010. Diabetes Care. 2010;33(Suppl1):S11–61. doi:10.2337/dc10-S011
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–1463. doi:10.1016/j.echo.2005.10.005
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: an Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314. doi:10.1016/j.echo.2016.01.011
   PubMed Web of Science ®Google Scholar
• Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97(5):473–483. doi:10.1161/01.cir.97.5.473
   PubMed Web of Science ®Google Scholar
• Maya L, Villarreal FJ. Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Mol Cell Cardiol. 2010;48(3):524–529. doi:10.1016/j.yjmcc.2009.06.021
   PubMed Web of Science ®Google Scholar
• Felício JS, Koury CC, Carvalho CT, et al. Present Insights on Cardiomyopathy in Diabetic Patients. Curr Diabetes Rev. 2016;12(4):384–395. doi:10.2174/1573399812666150914120529
   PubMedGoogle Scholar
• Park J, Kim JS, Kim SH, et al. Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study. Cardiovasc Diabetol. 2017;16(1):36. doi:10.1186/s12933-017-0519-5
   PubMed Web of Science ®Google Scholar
• Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond). 2004;107(6):539–557. doi:10.1042/cs20040057
   PubMed Web of Science ®Google Scholar
• Tsapas A, Avgerinos I, Karagiannis T, et al. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: a Systematic Review and Network Meta-analysis. Ann Intern Med. 2020;173(4):278–286. doi:10.7326/m20-0864
   PubMed Web of Science ®Google Scholar
• Chaudhary AK, Aneja GK, Shukla S, Razi SM. Study on Diastolic Dysfunction in Newly Diagnosed Type 2 Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin (HbA1C). J Clin Diagn Res. 2015;9(8):Oc20–22. doi:10.7860/jcdr/2015/13348.6376
   PubMedGoogle Scholar
• Saisho Y. β-cell dysfunction: its critical role in prevention and management of type 2 diabetes. World J Diabetes. 2015;6(1):109–124. doi:10.4239/wjd.v6.i1.109
   PubMed Web of Science ®Google Scholar
• Mannucci E, Monami M, Dicembrini I, Piselli A, Porta M. Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis. J Endocrinol Invest. 2014;37(5):477–495. doi:10.1007/s40618-014-0069-6
   PubMed Web of Science ®Google Scholar
• Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21–28. doi:10.1007/s00125-017-4390-4
   PubMed Web of Science ®Google Scholar
• Knapp M, Tu X, Wu R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 2019;40(1):1–8. doi:10.1038/s41401-018-0042-6
   PubMed Web of Science ®Google Scholar
• Gould KL, Nakagawa Y, Nakagawa K, et al. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography. Circulation. 2000;101(16):1931–1939. doi:10.1161/01.cir.101.16.1931
   PubMed Web of Science ®Google Scholar
• Adameova A, Dhalla NS. Role of microangiopathy in diabetic cardiomyopathy. Heart Fail Rev. 2014;19(1):25–33. doi:10.1007/s10741-013-9378-7
   PubMed Web of Science ®Google Scholar
• Tao L, Huang X, Xu M, et al. Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy. Mol Cell Endocrinol. 2020;518:110944. doi:10.1016/j.mce.2020.110944
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853. doi:10.1016/S0140-6736(98)07019-6
   PubMed Web of Science ®Google Scholar
• Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag. 2010;6:883–903. doi:10.2147/vhrm.S11681
   PubMedGoogle Scholar
• Huang R, Abdelmoneim SS, Nhola LF, Mulvagh SL. Relationship between HgbA1c and myocardial blood flow reserve in patients with type 2 diabetes mellitus: noninvasive assessment using real-time myocardial perfusion echocardiography. J Diabetes Res. 2014;2014:243518. doi:10.1155/2014/243518
   PubMed Web of Science ®Google Scholar